212 related articles for article (PubMed ID: 30569844)
1. Targeting Tumour Metastasis: The Emerging Role of Nanotechnology.
Visentin S; Sedić M; Pavelić SK; Pavelić K
Curr Med Chem; 2020; 27(8):1367-1381. PubMed ID: 30569844
[TBL] [Abstract][Full Text] [Related]
2. Nanotechnology-integrated ovarian cancer metastasis therapy: Insights from the metastatic mechanisms into administration routes and therapy strategies.
Huang Y; Li C; Zhang X; Zhang M; Ma Y; Qin D; Tang S; Fei W; Qin J
Int J Pharm; 2023 Apr; 636():122827. PubMed ID: 36925023
[TBL] [Abstract][Full Text] [Related]
3. Emerging nanomedicine-based strategies for preventing metastasis of pancreatic cancer.
Li YJ; Wu JY; Wang JM; Xiang DX
J Control Release; 2020 Apr; 320():105-111. PubMed ID: 31978441
[TBL] [Abstract][Full Text] [Related]
4. Nanotechnology-based intelligent drug design for cancer metastasis treatment.
Gao Y; Xie J; Chen H; Gu S; Zhao R; Shao J; Jia L
Biotechnol Adv; 2014; 32(4):761-77. PubMed ID: 24211475
[TBL] [Abstract][Full Text] [Related]
5. Bridging Bio-Nano Science and Cancer Nanomedicine.
Björnmalm M; Thurecht KJ; Michael M; Scott AM; Caruso F
ACS Nano; 2017 Oct; 11(10):9594-9613. PubMed ID: 28926225
[TBL] [Abstract][Full Text] [Related]
6. Active Targeting of Nano-Photosensitizer Delivery Systems for Photodynamic Therapy of Cancer Stem Cells.
Lin L; Xiong L; Wen Y; Lei S; Deng X; Liu Z; Chen W; Miao X
J Biomed Nanotechnol; 2015 Apr; 11(4):531-54. PubMed ID: 26310063
[TBL] [Abstract][Full Text] [Related]
7. Nanomedicine strategies for sustained, controlled and targeted treatment of cancer stem cells.
Gao J; Li W; Guo Y; Feng SS
Nanomedicine (Lond); 2016 Dec; 11(24):3261-3282. PubMed ID: 27854161
[TBL] [Abstract][Full Text] [Related]
8. Nanotechnology-aided advancement in the combating of cancer metastasis.
Avula LR; Grodzinski P
Cancer Metastasis Rev; 2022 Jun; 41(2):383-404. PubMed ID: 35366154
[TBL] [Abstract][Full Text] [Related]
9. pH-sensitive nano-systems for drug delivery in cancer therapy.
Liu J; Huang Y; Kumar A; Tan A; Jin S; Mozhi A; Liang XJ
Biotechnol Adv; 2014; 32(4):693-710. PubMed ID: 24309541
[TBL] [Abstract][Full Text] [Related]
10. Methods and assays for specific targeting and delivery of RNA nanoparticles to cancer metastases.
Rychahou P; Shu Y; Haque F; Hu J; Guo P; Evers BM
Methods Mol Biol; 2015; 1297():121-35. PubMed ID: 25896000
[TBL] [Abstract][Full Text] [Related]
11. Nanotechnology for the theranostic opportunity of breast cancer lung metastasis: recent advancements and future challenges.
Miao L; Kang Y; Zhang XF
Front Bioeng Biotechnol; 2024; 12():1410017. PubMed ID: 38882636
[TBL] [Abstract][Full Text] [Related]
12. Breast Cancer Bone Metastasis: A Narrative Review of Emerging Targeted Drug Delivery Systems.
Shao H; Varamini P
Cells; 2022 Jan; 11(3):. PubMed ID: 35159207
[TBL] [Abstract][Full Text] [Related]
13. Cancer bone metastases and nanotechnology-based treatment strategies.
Li Z; Zhang W; Zhang Z; Gao H; Qin Y
Expert Opin Drug Deliv; 2022 Oct; 19(10):1217-1232. PubMed ID: 35737871
[TBL] [Abstract][Full Text] [Related]
14. Targeting the extracellular signature of metastatic colorectal cancers.
Marchiò S; Arap W; Pasqualini R
Expert Opin Ther Targets; 2009 Mar; 13(3):363-79. PubMed ID: 19236157
[TBL] [Abstract][Full Text] [Related]
15. Targeting cancer metastasis with antibody therapeutics.
Yang H; Kuo YH; Smith ZI; Spangler J
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2021 Jul; 13(4):e1698. PubMed ID: 33463090
[TBL] [Abstract][Full Text] [Related]
16. Nanotechnology applications in diagnosis and treatment of metastasis.
Gupta AS
Nanomedicine (Lond); 2014 Jul; 9(10):1517-29. PubMed ID: 25253499
[TBL] [Abstract][Full Text] [Related]
17. Cancer Nanotechnology: Opportunities for Prevention, Diagnosis, and Therapy.
Zeineldin R; Syoufjy J
Methods Mol Biol; 2017; 1530():3-12. PubMed ID: 28150193
[TBL] [Abstract][Full Text] [Related]
18. Potential nanotechnologies and molecular targets in the quest for efficient chemotherapy in ovarian cancer.
Rhoda K; Choonara YE; Kumar P; Bijukumar D; du Toit LC; Pillay V
Expert Opin Drug Deliv; 2015 Apr; 12(4):613-34. PubMed ID: 25300775
[TBL] [Abstract][Full Text] [Related]
19. Nanocarrier-mediated drugs targeting cancer stem cells: an emerging delivery approach.
Malhi S; Gu X
Expert Opin Drug Deliv; 2015 Jul; 12(7):1177-201. PubMed ID: 25601619
[TBL] [Abstract][Full Text] [Related]
20. Emerging functional markers for cancer stem cell-based therapies: Understanding signaling networks for targeting metastasis.
Marquardt S; Solanki M; Spitschak A; Vera J; Pützer BM
Semin Cancer Biol; 2018 Dec; 53():90-109. PubMed ID: 29966677
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
